Association between typical electrocardiographic abnormalities and NT-proBNP elevation in a large cohort of patients with Chagas disease from endemic area.

[1]  A. Ribeiro,et al.  Value of the Electrocardiographic (P Wave, T Wave, QRS) Axis as a Predictor of Mortality in 14 Years in a Population With a High Prevalence of Chagas Disease from the Bambuí Cohort Study of Aging. , 2018, The American journal of cardiology.

[2]  Mohammad R. Ostovaneh,et al.  Association of Elevated NT-proBNP With Myocardial Fibrosis in the Multi-Ethnic Study of Atherosclerosis (MESA). , 2017, Journal of the American College of Cardiology.

[3]  P. Macfarlane,et al.  Major Electrocardiographic Abnormalities According to the Minnesota Coding System Among Brazilian Adults (from the ELSA-Brasil Cohort Study). , 2017, The American journal of cardiology.

[4]  A. Hasslocher-Moreno,et al.  2 nd Brazilian Consensus on Chagas Disease, 2015. , 2016, Revista da Sociedade Brasileira de Medicina Tropical.

[5]  A. Ribeiro,et al.  Longitudinal study of patients with chronic Chagas cardiomyopathy in Brazil (SaMi-Trop project): a cohort profile , 2016, BMJ Open.

[6]  A. Ribeiro,et al.  Electrocardiogram and Chagas disease: a large population database of primary care patients. , 2015, Global heart.

[7]  A. Ribeiro,et al.  Electrocardiographic Abnormalities in Elderly Chagas Disease Patients: 10‐Year Follow‐Up of the Bambuí Cohort Study of Aging , 2014, Journal of the American Heart Association.

[8]  C. Morillo,et al.  Chagas disease: an overview of clinical and epidemiological aspects. , 2013, Journal of the American College of Cardiology.

[9]  A. Ribeiro,et al.  Frequent electrocardiographic abnormalities and associated conditions in Chagas disease patients , 2013 .

[10]  E. Bocchi,et al.  Mode of Death on Chagas Heart Disease: Comparison with Other Etiologies. A Subanalysis of the REMADHE Prospective Trial , 2013, PLoS neglected tropical diseases.

[11]  B. Custer,et al.  Ten-Year Incidence of Chagas Cardiomyopathy Among Asymptomatic Trypanosoma cruzi–Seropositive Former Blood Donors , 2013, Circulation.

[12]  A. Ribeiro,et al.  Electrocardiographic Abnormalities in Trypanosoma cruzi Seropositive and Seronegative Former Blood Donors , 2013, PLoS neglected tropical diseases.

[13]  Mauro M. Teixeira,et al.  Diagnosis and management of Chagas disease and cardiomyopathy , 2012, Nature Reviews Cardiology.

[14]  A. Ribeiro,et al.  The prognostic significance of electrocardiographic changes in Chagas disease. , 2012, Journal of electrocardiology.

[15]  Federico Lombardi,et al.  T‐Wave Amplitude Variability and the Risk of Death in Chagas Disease , 2011, Journal of cardiovascular electrophysiology.

[16]  A. Ribeiro,et al.  Plasma B-type natriuretic peptide as a predictor of mortality in community-dwelling older adults with Chagas disease: 10-year follow-up of the Bambui Cohort Study of Aging. , 2010, American journal of epidemiology.

[17]  A. Pinto,et al.  Correlation between BNP Levels and Doppler Echocardiographic Parameters of Left Ventricle Filling Pressure in Patients with Chagasic Cardiomyopathy , 2009, Echocardiography.

[18]  W Frank Peacock,et al.  State of the art: Using natriuretic peptide levels in clinical practice , 2008, European journal of heart failure.

[19]  A. Maisel,et al.  State-of-the-Art PaperNatriuretic Peptides , 2007 .

[20]  A. Ribeiro,et al.  N-terminal proBNP levels in patients with Chagas disease: a marker of systolic and diastolic dysfunction of the left ventricle. , 2007, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[21]  P. Barbosa.  Noninvasive prognostic markers for cardiac death and ventricular arrhythmia in long-term follow-up of subjects with chronic Chagas' disease , 2007 .

[22]  P. R. Benchimol Barbosa.  Noninvasive prognostic markers for cardiac death and ventricular arrhythmia in long-term follow-up of subjects with chronic Chagas' disease. , 2007, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[23]  A. C. P. Barretto,et al.  Avaliação de pacientes assintomáticos com forma crônica da doença de Chagas através da análise do eletrocardiograma dinâmico, ecocardiograma e do peptídeo natriurético tipo B , 2006 .

[24]  A. Hasslocher-Moreno,et al.  Development and validation of a risk score for predicting death in Chagas' heart disease. , 2006, The New England journal of medicine.

[25]  C. Fuganti,et al.  Evaluation of asymptomatic patients with chronic Chagas disease through ambulatory electrocardiogram, echocardiogram and B-Type natriuretic peptide analyses. , 2006, Arquivos brasileiros de cardiologia.

[26]  Bruno Lococo,et al.  Indicadores clínicos de progresión de la miocarditis chagásica crónica , 2005 .

[27]  A. Ribeiro,et al.  Brain natriuretic peptide measurement in Chagas heart disease: marker of ventricular dysfunction and arrhythmia. , 2005, International Journal of Cardiology.

[28]  A. Hasslocher-Moreno,et al.  T-wave axis deviation as an independent predictor of mortality in chronic Chagas' disease. , 2004, The American journal of cardiology.

[29]  A. Hasslocher-Moreno,et al.  Prognostic Value of QT Interval Parameters for Mortality Risk Stratification in Chagas' Disease Results of a Long‐Term Follow‐Up Study , 2003, Circulation.

[30]  A. Ribeiro,et al.  Brain natriuretic peptide and left ventricular dysfunction in Chagas' disease , 2002, The Lancet.

[31]  A. Ribeiro,et al.  A Narrow QRS Does Not Predict a Normal Left Ventricular Function in Chagas' Disease , 2000, Pacing and clinical electrophysiology : PACE.

[32]  D. Dávila,et al.  Electrocardiographic abnormalities and left ventricular systolic function in Chagas' heart disease. , 1990, International journal of cardiology.

[33]  R. Morrow,et al.  Relationship of electrocardiographic abnormalities and seropositivity to Trypanosoma cruzi within a rural community in northeast Brazil. , 1983, American heart journal.

[34]  C. Chagas,et al.  Cardiac form of American Trypanosomiasis , 1922 .